Analyzing UpHealth (UPH) & The Competition

UpHealth (NYSE:UPHGet Rating) is one of 33 public companies in the “Health services” industry, but how does it weigh in compared to its competitors? We will compare UpHealth to similar companies based on the strength of its analyst recommendations, risk, profitability, institutional ownership, dividends, valuation and earnings.

Profitability

This table compares UpHealth and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
UpHealth -204.99% -18.80% -11.75%
UpHealth Competitors -325.87% -481.74% -38.64%

Analyst Ratings

This is a summary of recent ratings and recommmendations for UpHealth and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UpHealth 0 1 1 0 2.50
UpHealth Competitors 7 130 274 0 2.65

UpHealth currently has a consensus target price of $3.50, indicating a potential upside of 856.28%. As a group, “Health services” companies have a potential upside of 117.12%. Given UpHealth’s higher probable upside, analysts plainly believe UpHealth is more favorable than its competitors.

Valuation & Earnings

This table compares UpHealth and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
UpHealth $123.79 million -$340.90 million -0.16
UpHealth Competitors $1.36 billion -$98.47 million 29.16

UpHealth’s competitors have higher revenue and earnings than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

48.6% of shares of all “Health services” companies are held by institutional investors. 41.3% of UpHealth shares are held by company insiders. Comparatively, 21.6% of shares of all “Health services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

UpHealth has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500. Comparatively, UpHealth’s competitors have a beta of 1.48, indicating that their average share price is 48% more volatile than the S&P 500.

Summary

UpHealth competitors beat UpHealth on 7 of the 12 factors compared.

UpHealth Company Profile

(Get Rating)

UpHealth, Inc. operates as a digital health services company. It provides a patient-centric digital health technologies and tech-enabled services to manage health and integrate care in the areas of integrated care management, virtual care infrastructure, and services. The company's solutions include Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform that delivers primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding licensed pharmacy that dispenses prescribed medications shipped directly to patients. UpHealth, Inc. is headquartered in Delray Beach, Florida.

Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.